Search

everythinglearnresearchcommunity

for

Search:↓

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Minoxidil lowers blood pressure and increases heart efficiency, but may raise lung artery pressure in some people.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Finasteride use can cause depression-like behavior in male rats.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Some chemicals absorbed through the skin can cause serious health problems.

Finasteride slows down motherly behavior in first-time pregnant rats.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Minoxidil helps protect and rebuild elastic fibers in arteries, improving artery function, especially in older females.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

Micro-current stimulation may promote hair growth more effectively than standard treatments.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Activating TSPO helps protect the retina from damage caused by high eye pressure in glaucoma.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Researchers developed a mouse model that tracks hair growth using bioluminescence, improving accuracy in studying hair cycles.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Finasteride reduces movement issues in Parkinson's disease rats.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

New treatments for lupus show promise, but more research is needed, especially for children.